- Home
- GSK
as 11-20-2024 4:00pm EST
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
| Founded: | 1715 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 76.5B | IPO Year: | N/A |
| Target Price: | $45.50 | AVG Volume (30 days): | 8.2M |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.81 | EPS Growth: | -58.92 |
| 52 Week Low/High: | $32.83 - $45.93 | Next Earning Date: | 10-30-2024 |
| Revenue: | $41,966,224,352 | Revenue Growth: | 5.59% |
| Revenue Growth (this year): | 6.5% | Revenue Growth (next year): | 4.54% |
Latest GSK plc (Each representing two) News
GSK Breaking Stock News: Dive into GSK Ticker-Specific Updates for Smart Investing
Benzinga
2 days ago
GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
GlobeNewswire
3 days ago
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
Morningstar Research
3 days ago
Analyst Report: GSK plc
Yahoo Finance Video
6 days ago
How analysts are reacting to RFK Jr. as Trump's HHS pick
Yahoo Finance Video
6 days ago
Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick
Yahoo Finance
6 days ago
Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
The Wall Street Journal
6 days ago
Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too
The Wall Street Journal
6 days ago
Trump’s RFK Jr. Pick Weighs on Vaccine Makers
Compare GSK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GSK GSK plc (Each representing two) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.